Primary medical therapy for BRAFV600E-mutant melanoma brain metastases—is this good enough?

Tim J. Kruser; Michael A. Vogelbaum

doi:10.1016/S1470-2045(17)30633-2

Primary medical therapy for BRAF^V600E-mutant melanoma brain metastases—is this good enough?

Tim J. Kruser, Michael A. Vogelbaum

Radiation Oncology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e508
Journal	The Lancet Oncology
Volume	18
Issue number	9
DOIs	https://doi.org/10.1016/S1470-2045(17)30633-2
State	Published - Sep 2017

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(17)30633-2

Cite this

@article{fac08060ed04449382aa66e4bc3678e5,

title = "Primary medical therapy for BRAFV600E-mutant melanoma brain metastases—is this good enough?",

author = "Kruser, {Tim J.} and Vogelbaum, {Michael A.}",

year = "2017",

month = sep,

doi = "10.1016/S1470-2045(17)30633-2",

language = "English (US)",

volume = "18",

pages = "e508",

journal = "The Lancet Oncology",

issn = "1470-2045",